Home » Topics » Regulatory

Regulatory
RSS

Afinitor approved in U.S. for new indication

April 30, 2012

FDA approves sNDA for Votrient

April 30, 2012

First medicine approved in E.U. for Cushing's disease

April 25, 2012

Alimera announces first marketing authorization for Iluvien in E.U.

April 25, 2012

Novartis seeking approval in Japan of Glivec for new indication

April 17, 2012

Eisai launches new formulation of rufinamide in U.K.

April 16, 2012

European Commission approves Humira for new indication

April 12, 2012

Korlym now available in U.S.

April 11, 2012

FDA approves adjunct radioactive diagnostic for Alzheimer's disease

April 10, 2012

New product approved for T-cell leukemia-lymphoma

March 30, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
FDA greenlights Medtronic Onyx subdural hematoma treatment
BioWorld MedTech
Sometimes the darkest products (names) bring a bright spot of news to their developers, as the U.S. FDA clearance for Galway, Ireland-based Medtronic plc's Onyx...